Cannabinoid Clinical Trials: PTSD and Substance Use
Cannabinoid clinical trials PTSD substance use reveal that cannabis does not reduce the effectiveness of trauma-focused treatments. People with PTSD and substance use disorders benefit from evidence-based therapies despite cannabis use. These trials…
Cannabis Use and Trauma-Focused Treatment for PTSD
Cannabis use trauma-focused treatment PTSD shows meaningful benefits for people with co-occurring substance use disorders. Trauma-focused treatments remain effective regardless of cannabis use. Cannabis use should not delay evidence-based PTSD care.
Cannabis Use and Trauma-Focused Treatment for PTSD and SUD
This meta-analysis examines cannabis use trauma-focused treatment PTSD SUD meta-analysis outcomes in patients with co-occurring disorders. Evidence shows trauma-focused therapies remain effective despite cannabis use. These findings support offering…
Meta-Analysis of Cannabis Use and Trauma-Focused Treatment in PTSD and SUD
This meta-analysis examines cannabis use and trauma-focused treatment PTSD SUD meta-analysis outcomes in patients with co-occurring disorders. Findings show trauma-focused treatments remain effective despite cannabis use. Clinicians should consider these…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…